La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Warner Bros. Discovery a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Warner Bros. Discovery..

Warner Bros. Discovery (NASDAQ:WBD) Azioni, Catena delle Opzioni

Warner Bros. Discovery

Warner Bros. Discovery was formed in 2022 through the combination of WarnerMedia and Discovery Communications. It operates in three global business segments: studios, networks, and direct-to-consumer. Warner Bros. Pictures is the crown jewel of the studios business, producing, distributing, and licensing movies and television shows. The networks business consists of basic cable networks, such as CNN, TNT, TBS, Discovery, HGTV, and the Food Network. Direct-to-consumer includes HBO and the firm's streaming platforms, which have now been consolidated to Max and Discovery+. Much of the DTC content is created within the firm's other two business segments. Each segment operates with a global reach, with Max available in over 60 countries.

Warner Bros. Discovery, Inc. - Series A Common Stock

Warner Bros. Discovery Inc

WeBuild SpA

WARNER BROS. DISCOVERY SRS A ORD

WIIM

RNAZ

TransCode Therapeutics shares are trading higher after the company announced the safety review committee monitoring its Phase 1 clinical trial has unanimously approved the opening of the second cohort of patients.

BWS Financial analyst Hamed Khorsand maintains Interparfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Buy and maintains $172 price target.

News

Price Target

Analyst Ratings

IPAR

BWS Financial Maintains Buy on Interparfums, Maintains $172 Price Target

Compass Point analyst Chase White maintains Core Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) with a Buy and raises the price target from $18 to $20.

Core Scientific, Inc. - Class A Common Stock

CORZ

Compass Point Maintains Buy on Core Scientific, Raises Price Target to $20

After the closing bell on Monday, Nucor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) reported better-than-expected third-quarter financial results and announced it expects its fourth-quarter earnings to <a href="https://www.benzinga.com/news/earnings/24/10/41440667/nucor-stock-falls-after-q3-results-weak-q4-eps-guidance-details">decline to $1.05 per share</a>.
Nucor reported quarterly earnings of $1.49 per share, which beat the analyst consensus estimate of $1.47. Quarterly revenue came in at $7.44 billion, which beat the analyst consensus estimate of $7.28 and is a decrease from sales of $8.78 billion from the same period last year.
"Thank you to our Nucor teammates for continuing to set new records for safety performance while generating over $1.30 billion of cash from operations for the quarter," said Leon Topalian, Nucor's CEO. "Nucor's market leadership, product diversity, and strong balance sheet enable us to provide meaningful returns to shareholders and execute our growth strategy even in the face of market uncertainty."
Nucor said it expects its fourth-quarter earnings to decline to $1.05 per share amid decreased steel mill segment earnings caused by lower average selling prices and decreased volumes.
Nucor shares fell 2.6% to trade at $142.35 on Wednesday.
These analysts made changes to their price targets on Nucor following earnings announcement.
<ul>
<li>Morgan Stanley analyst Carlos De Alba maintained Nucor with an Overweight and lowered the price target from $170 to $166.</li>
<li>JP Morgan analyst Bill Peterson maintained the stock with an Overweight and lowered the price target from $170 to $168. </li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41488681/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Tech Stocks Delivering High-Dividend Yields</a></li>
</ul>

Nucor Analysts Cut Their Forecasts After Q3 Earnings

In a significant development for psychedelics research, a <a href="https://www.benzinga.com/topic/drug-enforcement-administration">Drug Enforcement Administration (DEA)</a> administrative law judge has rejected the agency's request to block key witnesses and evidence in an upcoming hearing. The case, <a href="https://www.benzinga.com/markets/cannabis/24/08/40613739/dea-schedules-hearing-on-proposed-ban-of-psychedelics-doi-doc-amid-researchers-concerns">set for November</a>, challenges the DEA's proposed ban on two psychedelic compounds, DOI and DOC, which are used in research.
<h3 class="wp-block-heading">DEA&#8217;s Argument On Irrelevance Of Testimonies Rejected</h3>
The DEA sought to exclude certain experts and materials, claiming they were "irrelevant" to the case. However, as Marijuana Moment <a href="https://www.marijuanamoment.net/dea-judge-denies-agencys-request-to-block-witnesses-in-hearing-challenging-proposed-psychedelics-ban/">reported</a>, administrative Law Judge Paul Soeffing <a href="https://www.documentcloud.org/documents/25245031-dea-alj-doi-doc-evidence?responsive=1&amp;title=1">denied</a> the motion, stating it was premature to determine the relevance of the testimony. This is seen as a partial win for groups like Students for Sensible Drug Policy (SSDP) and Panacea Plant Sciences (PPS), which oppose the ban.
The hearing aims to shed light on the proposed ban, which opponents say lacks evidence of abuse potential or health risks. Researchers argue there&#8217;s insufficient justification for classifying DOI and DOC as high-risk substances, as scientific literature shows no documented deaths or significant adverse reactions solely from these compounds. Studies over the past 35 years suggest DOI and DOC may effectively treat chronic pain, opioid and alcohol addiction and other mental health disorders.
<h3 class="wp-block-heading">Advocates Speak Out Against Schedule I Designation</h3>
Kat Murti, executive director of SSDP, expressed relief at the judge's decision. "The DEA is trying to force medical research into the dark ages by criminalizing DOI and DOC—essential research chemicals in pre-clinical psychiatry and neurobiology." She added that the judge's decision is "a victory not only for scientific integrity but for the tens of thousands of Americans suffering from depression, anxiety, and chronic pain."
David Heldreth, CEO of PPS, echoed these sentiments. "We hope the rest of the hearing continues to go our way." Heldreth and his organization <a href="https://www.benzinga.com/markets/cannabis/22/08/28654017/deas-latest-proposal-for-psychedelics-banning-gets-archived">have been at the forefront</a> of the legal challenge against the DEA, fighting for the continued use of DOI and DOC in research.
<h3 class="wp-block-heading">An Ongoing Challenge</h3>
This resolution is part of a <a href="https://www.benzinga.com/markets/cannabis/22/08/28606682/deas-psychedelic-drugs-banning-attempt-this-are-the-two-hallucinogens-under-discussion">longer battle</a> between the DEA and the scientific community. The DEA&#8217;s action to place DOI and DOC in <a href="https://www.benzinga.com/topic/federal-schedule-i">Schedule I</a> of the Controlled Substances Act <a href="https://www.benzinga.com/government/24/04/38053487/dea-revisits-proposed-ban-on-two-psychedelic-compounds-researchers-disagree-insist-on-hearings">dates back to 2018</a>, and has been met with <a href="https://www.benzinga.com/markets/cannabis/24/07/39975673/dea-faces-backlash-over-psychedelics-ban-proposal-from-student-advocacy-group">significant pushback</a>. These compounds are unscheduled at the moment and have been pivotal in research aimed at treating conditions like chronic pain, addiction and mental health disorders. Opponents argue that a Schedule I designation would severely impede scientific research on these substances.
The hearing is scheduled to run from November 12-22, with a final meeting on November 25, as researchers and advocates continue their fight to prevent the ban on DOI and DOC.
Cover image made with AI.

Cannabis

Government

Psychedelics

Regulations

Legal

DEA Faces Setback As Judge Denies Request To Block Witnesses In Psychedelics Ban Hearing

Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) shares are trading lower Wednesday afternoon after an analyst reported that iPhone 16 orders were cut <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41350919/apple-analyst-predicts-a-september-quarter-revenue-beat-allays-fears-over-shorter-i">by around 10 million units</a>.
What To Know: Apple analyst Ming-Chi Kuo released a <a href="https://medium.com/@mingchikuo/iphone-16-orders-cut-by-around-10-million-units-for-4q24-1h25-no-evidence-yet-that-apple-48c126a33bc6">report</a> Wednesday afternoon suggesting that iPhone 16 orders were slashed by about 10 million units for the three-quarter period spanning the fourth quarter of 2024 through the first half of 2025.
The analyst said his latest industry survey showed that most of the cuts impact the non-Pro models. Given the cuts, Kuo expects <a href="https://www.benzinga.com/topic/iphone-16">iPhone 16</a> production in the second half of 2024 to total 84 million units, down from his prior forecast of around 88 million units.
Kuo also noted that iPhone SE4 production is slated to start in December. Production projections currently sit around 8.6 million units from launch to the end of the first quarter, he said. 
&#8220;Apple's iPhone revenue in 4Q24 may not fully reflect the impact of production cuts, as the gap between production and sell-through in 4Q23 was larger than in 4Q24, and the product mix in 4Q24 is more favorable (with increased production of the Pro Max model for Sep-Oct),&#8221; the analyst said.
&#8220;However, iPhone revenues are expected to come under pressure in 1H25 due to a YoY shipment decline and a less favorable product mix due to the launch of SE4.&#8221;
See Also: <a href="https://www.benzinga.com/success-stories/24/10/41441641/apple-ceo-tim-cook-says-apple-intelligence-will-make-products-profoundly-different-new-ai-technol">Apple CEO Tim Cook Says Apple Intelligence Will Make Products &#8216;Profoundly Different&#8217;: New AI Technology Will Get Consumers &#8216;On A Different Technology Curve&#8217;</a>
Kuo acknowledged that some are optimistic that Apple Intelligence could significantly boost iPhone shipments, but he suggested that order cuts show those expectations may not materialize in the short term.
&#8220;I believe that Apple is best positioned to succeed in on-device AI, and I am confident about the long-term potential for Apple Intelligence to become a popular paid service. However, significant growth in iPhone shipments will likely require further hardware innovation to accompany this AI development,&#8221; Kuo said.
Separately, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-10-23/goldman-apple-to-pay-89-million-following-cfpb-card-probe?sref=TBDibEcD&amp;embedded-checkout=true">reported </a>Wednesday that Apple and Goldman Sachs will have to pay over $89 million to settle an investigation into their credit card joint venture. 
The&nbsp;Consumer Financial Protection Bureau&nbsp;reportedly said Apple and Goldman &#8220;illegally sidestepped&#8221; their legal obligations for Apple Card borrowers. The agency ordered Goldman to pay at least $19.8 million in redress, as well as a civil money penalty of $45 million. Apple has been ordered to pay a $25 million civil money penalty. 
AAPL Price Action: <a href="http://benzinga.com/quote/aapl">Apple shares</a> were down 2.88% at $229.03 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Apple.

Movers

AAPL

Apple Stock Is Sliding Wednesday: What's Going On?

Scotiabank analyst Maher Yaghi maintains Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) with a Sector Perform and lowers the price target from $47.25 to $47.

Scotiabank Maintains Sector Perform on Verizon Communications, Lowers Price Target to $47

TZOO

Travelzoo shares are trading higher after the company announced better-than-expected Q3 EPS results and a repurchase program for up to one million shares.

Scotiabank analyst Cameron Bean maintains Topaz Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TPZ#TSX">TPZ</a>) with a Sector Outperform and raises the price target from C$34 to C$35.

TSX:TPZ

Scotiabank Maintains Sector Outperform on Topaz Energy, Raises Price Target to C$35

BTIG analyst Gray Powell maintains Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) with a Buy and raises the price target from $57 to $63.

BTIG Maintains Buy on Dynatrace, Raises Price Target to $63

McDonald&#39;s Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mcd#NYSE">MCD</a>)&nbsp;has gained 24.2% in the past three months, outperforming the Zacks <a href="https://www.zacks.com/stocks/industry-rank/industry/retail-restaurants-160">Retail - Restaurants</a> industry, the Zacks <a href="https://www.zacks.com/stocks/industry-rank/sector/retail-wholesale-3">Retail-Wholesale</a> sector and the S&amp;P 500 Index, which rose 20.4%, 10.7% and 7.4%, respectively.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/06/82254.jpg?v=663129858" style="height:292px; width:624px" /> 
Image Source: Zacks Investment Research
The company is benefiting from its focus on enhancing customer experiences through its 4D Growth strategy and increased global franchise units. This, alongside an effective capital allocation strategy, has added to the uptrend, given its focus on maintaining shareholder value. 
MCD stock has also outperformed some major industry players, including Yum! Brands, Inc. YUM, Domino&#39;s Pizza, Inc. DPZ and Wingstop Inc. WING, in the past three months. In the said time frame, YUM and DPZ have rallied 5.9% and 0.5%, respectively, while WING has lost 1.2%.
<h3>Factors Driving MCD Stock</h3>
4D Growth Pillar: McDonald&#39;s continues unraveling new and improved ways to enhance customer experiences and drive growth. One of the company&#39;s primary tools to offer customers a more personalized and convenient experience is the 4D Growth Pillar, wherein 4D stands for Digital, Delivery, Drive Thru and Development. The Digital aspect encompasses the company&#39;s top-tier loyalty program available on its digital platform, which now has more than 150 million 90-day active users in approximately 50 markets globally.&nbsp; It anticipates 90-day active users to reach 250 million and annual loyalty system-wide sales to reach $45 billion by 2027. 
Regarding the Delivery and Drive Thru aspects, the company offers delivery services through McDelivery or third-party delivery providers in about 100 global markets, which represent more than 85% of its restaurants. Considering drive-thrus under the delivery section, the company houses quite a number of drive-thru locations across the globe, with more than 27,000 drive-thru locations globally. With the increase in delivery sales mix over the past few years, mainly in Australia, Canada and the United States, and leveraging its long-term strategic partnerships with delivery providers, the company aims to offer seamless customer experiences. 
Considering the Development aspect, McDonald&#39;s is banking on increased demand patterns globally and increasing its foothold by boosting its presence in existing markets and by entering new ones. The company is planning to open more than 2,100 new restaurants globally in 2024, including 500 openings in the United States and International Operated Markets (IOM) segment and 1,600 (including nearly 1000 in China) inaugurations in the International Developmental Licensed (IDL) market. Furthermore, it aims to open 50,000 restaurants by 2027. 
Franchised Revenues Offer Stability: Among the total restaurants worldwide of McDonald&#39;s, 95% were franchised restaurants as of June 30, 2024. The company operates in three reportable segments, wherein the U.S. segment has about 95% franchised ownership mix, the IOM segment has 89% franchised ownership mix and the IDL segment has 98% franchised ownership mix. 
This asset-light business strategy, having more franchised store units across the world, makes its operations less susceptible to market volatility than the company running its outlets on its own. The diversity in market conditions and regulatory hurdles across different nations would make it difficult for MCD to handle operations. This business strategy will offer it higher profit margins and a stable source of revenues. During the first six months of 2024, about 60.5% of revenues came from franchised restaurants. 
Effective Capital Allocation Strategy: The company follows an effective capital allocation strategy, wherein it aims to utilize its free cash flow in new business opportunities, dividend payouts and share repurchases. MCD&#39;s way of prioritizing shareholder value apart from business investments is encouraging in the industry. 
Maintaining its history of increasing dividend payments for 47 consecutive years, McDonald&#39;s has again announced a hike in its quarterly cash dividend on Sept. 25, 2024. It raised its quarterly dividend by 6% to $1.77 per share ($7.08 per share annually) from $1.67 per share ($6.68 per share annually). The dividend is to be paid on Dec. 16, 2024 to shareholders as of Dec. 2.
<h3>Estimate Trend Favors McDonald&#39;s</h3>
The Zacks Consensus Estimate for MCD&#39;s third-quarter and 2024 earnings per share (ETF:EPS) has trended upward in the past seven days. The uptrend can be witnessed from the chart given below.
EPS Trend
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/d9/82252.jpg?v=159574847" /> 
Image Source: Zacks Investment Research
<h2>MCD Trading Above 50 &amp; 200-Day SMA</h2>
Technical indicators suggest a continued strong performance for McDonald&#39;s. From the graphical representation given below, it can be observed that MCD stock is trading above both the 50-day simple moving average (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sma#NYSE">SMA</a>) and 200-day SMA, signaling a bullish trend. The technical strength underscores positive market sentiment and confidence in MCD&#39;s financial health and prospects.
50 &amp; 200-Day Moving Average
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/32/82255.jpg?v=162340666" /> 
Image Source: Zacks Investment Research
<h2>MCD Trading at a Discount</h2>
McDonald&#39;s is currently trading at a discount compared with the industry peers on a forward 12-month price-to-earnings (P/E) ratio basis. The discounted valuation indicates that despite the recent stock price increase in the past three months, it remains an attractive option for investors looking for a suitable entry point.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c5/82253.jpg?v=1631045805" /> 
Image Source: Zacks Investment Research
<h2>Hurdles to MCD&#39;s Momentum</h2>
The tailwinds discussed above is helping McDonald&#39;s to move through the ongoing macro challenges and inflationary risks. However, headwinds like soft comparable store sales and high costs and expenses are pulling back the growth prospects to some extent. 
Soft Comps: McDonald&#39;s is facing challenges regarding weaker comparable store sales growth. The company&#39;s comps are hurt mainly due to negative comparable guest counts witnessed in the U.S. market and negative comparable sales in France witnessed under the IOM segment. The international market&#39;s trends are unfavorable since customers are wary of discretionary spending given the ongoing market challenges. 
Under the IDL segment, the continued impact of the war in the Middle East and negative comparable sales in China have resulted in declining comps. For the first six months of 2024, comparable sales under this segment decreased 0.8%. 
High Cost &amp; Expenses: The persisting inflationary pressures are hurting the company&#39;s margins. During the first six months of 2024, the company&#39;s total operating costs and expenses escalated 4% year over year to $7 billion due to increased restaurant and occupancy expenses along with selling, general and administrative expenses. 
The company anticipates operating margin to remain pressurized in the near term with labor inflation expected to be in the high single digits in 2024.
<h2>Is it a Wise Decision to Add MCD to Your Portfolio Now?</h2>
As discussed above, despite the ongoing macro hurdles and inflationary risks, McDonald&#39;s is gaining momentum in this competitive industry through its top-tier business strategies. The core business strategies of the company highlight its aim of delivering enhanced and personalized customer experiences, making strategic investments in growth opportunities and maintaining a consistent shareholder value. 
With the goals set through 2027 and the recent take on the dividend hike, along with increased franchised units, the company seems to be well-positioned to move through the uncertainties and deliver an outperformance in the upcoming period. 
Thus, based on the overall discussion and the trends of technical indicators, it is suggested to the existing investors to hold on to this Zacks Rank #3 (Hold) company&#39;s shares for now, whereas new investors might want to wait for a more favorable entry point given high costs and weaker comparable store sales growth.
<a href="https://www.zacks.com/stock/news/2356040/mcdonald-s-stock-jumps-24-in-3-months-should-you-buy-sell-or-hold?cid=CS-BENZ-FT-analyst_blog|most_popular_stocks-2356040">To read this article on Zacks.com click here.</a>

Restaurants

Trading Ideas

General

WING

McDonald's Stock Jumps 24% In 3 Months: Should You Buy, Sell Or Hold?

OKYO

OKYO Pharma shares are trading higher after the company announced it dosed its first patient in a clinical trial to meet Neuropathic Corneal pain.

Scotiabank analyst Orest Wowkodaw maintains Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) with a Sector Perform and lowers the price target from $53 to $52.

Scotiabank Maintains Sector Perform on Freeport-McMoRan, Lowers Price Target to $52

With less than two weeks to the <a href="https://www.benzinga.com/topic/election-day">ballot vote</a>, the debate around Florida's<a href="https://www.benzinga.com/markets/cannabis/24/10/41405555/floridas-cannabis-amendment-record-spending-unlikely-alliances-and-criticism-from-the-catholic-c"> Amendment 3 </a>is heating up. Trulieve Cannabis Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) CEO Kim Rivers came out swinging in an appearance on a WESH2 <a href="https://www.wesh.com/article/trulieve-ceo-anti-amendment-3-recreational-cannabis-ads-distortions/62684977">news report</a> in which she described the anti-cannabis ads running throughout the state as &#8220;distortions.&#8221;
Rivers has taken issue with the portrayal of Amendment 3 in <a href="https://www.benzinga.com/markets/cannabis/24/10/41405555/floridas-cannabis-amendment-record-spending-unlikely-alliances-and-criticism-from-the-catholic-c">political ads</a> that claim the measure would create a cannabis monopoly in the state. 
&#8220;The economic door to prosperity would be open to many,&#8221; Rivers stated, dismissing the suggestion that the amendment would only benefit large corporations like Trulieve. 
The initiative, she argues, is about broadening opportunities in an industry projected for <a href="https://www.benzinga.com/markets/cannabis/24/10/41335229/cannabis-industrys-130b-growth-potential-top-states-for-investment-as-financial-institutions-set">explosive growth</a>.
During a recent visit to one of Trulieve's 155 <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/markets/cannabis/24/07/39871979/floridas-medical-cannabis-market-sees-explosive-growth-ahead-of-november-legalization-ballot&amp;ved=2ahUKEwimgou_-qSJAxWrrJUCHULWIkgQFnoECBkQAQ&amp;usg=AOvVaw0aYsig6m9Yhjuv_bk1bdHr">dispensaries</a>, Rivers spoke to employees about the significance of the amendment, which would legalize recreational cannabis for adults over 21.
<h3 class="wp-block-heading">Addressing Child Safety Concerns</h3>
One of the central points of contention in the opposition's campaign is the claim that legalizing cannabis will expose children to products packaged to resemble candy. Rivers has been vocal in rebutting these assertions.
 &#8220;These are adult products, packaged for adults, sold to adults,&#8221; she said. 
Rivers explained that recreational cannabis, like medical marijuana, would adhere to strict packaging guidelines designed to prevent any appeal to children.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
Her point was reinforced by Trulieve Medical Director Dr. Terel Newton, who added, &#8220;You won't see bright colors, animals, or neon packaging that would attract kids.&#8221;
According to Rivers, these types of regulations would continue under an adult-use program, ensuring that products are marketed responsibly.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41365515/ron-desantis-pregnant-pigs-and-floridas-cannabis-legalization-battle-over-constitutional-amendme">Ron DeSantis, Pregnant Pigs And Florida&#8217;s Cannabis Legalization: Battle Over Constitutional Amendment Rages</a>
<h3 class="wp-block-heading">Fear Vs Facts</h3>
For Rivers, the campaign against Amendment 3 is built on fear rather than facts.
&#8220;And I would fully expect and anticipate that those laws and those restrictions will continue in the state of Florida with the adult use program,&#8221; she told the WESH reporter. I think it is really critical for folks to understand what this is and what this is not.&#8221; 
The fight against misleading ads and scary tactics in Florida had another <a href="https://www.benzinga.com/markets/cannabis/24/10/41411270/desantis-doubles-down-with-new-taxpayer-funded-anti-marijuana-ads-one-links-cannabis-to-domestic">recent episode</a> when Gov. Ron DeSantis leveraged the Florida Department of Education to fund a new ad campaign warning against cannabis. 
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/10/41303141/fact-check-desantis-why-floridas-weed-legalization-does-not-mean-smoking-in-schools">Fact-Check DeSantis: Why Florida&#8217;s Weed Legalization Does Not Mean Smoking In Schools</a></li>
</ul>
Cover: Photo by <a href="https://pixabay.com/es/users/jessica45-2055892/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=1409763">jessica45</a> in <a href="https://pixabay.com/es//?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=1409763">Pixabay</a>

Politics

Markets

TCNNF

Trulieve CEO Kim Rivers Calls Out 'Distortions' In Ads Opposing Florida's Cannabis Amendment

Scotiabank analyst Mario Saric maintains ALLIED PROPS REAL ESTATE INV TST (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AP#TSX">AP</a>) with a Sector Outperform and raises the price target from C$21 to C$22.

TSX:AP

Scotiabank Maintains Sector Outperform on ALLIED PROPS REAL ESTATE INV TST, Raises Price Target to C$22

<a href="https://x.com/mingchikuo/status/1849144029423997038" title="https://x.com/mingchikuo/status/1849144029423997038">https://x.com/mingchikuo/status/1849144029423997038</a>

TSLA

Analyst Ming-Chi Kuo Post On X, "Tesla survey and prediction updates: 1. The more affordable new model (dubbed "Model 2" by some) is unlikely to enter mass production until 2H25 at the earliest. 2. The Model Y refresh is expected to start mass production in 1Q25."

Apple Inc. is nearing production of updated MacBook Airs with M4 chips for release in early 2025, a follow-up to a wave of new Macs that are coming next week, according to people familiar with the matter.&nbsp;
<a href="https://www.bloomberg.com/news/articles/2024-10-23/apple-makes-headway-on-m4-macbook-air-and-plans-new-low-end-ipad?srnd=phx-technology&amp;embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2024-10-23/apple-makes-headway-on-m4-macbook-air-and-plans-new-low-end-ipad?srnd=phx-technology&amp;embedded-checkout=true">https://www.bloomberg.com/news/articles/2024-10-23/apple-makes-headway-on-m4-macbook-air-and-plans-new-low-end-ipad?srnd=phx-technology&amp;embedded-checkout=true</a>

'Apple Makes Headway on M4 MacBook Air and Plans New Low-End iPad' - Bloomberg

JP Morgan analyst Mark Murphy maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Overweight and lowers the price target from $19 to $17.

PATH

JP Morgan Maintains Overweight on UiPath, Lowers Price Target to $17

JP Morgan analyst Brian Ossenbeck maintains TFI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) with a Overweight and lowers the price target from $181 to $178.

TFII

JP Morgan Maintains Overweight on TFI International, Lowers Price Target to $178

Analysts are weighing in after Starbucks Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) on Tuesday reported worse-than-expected preliminary fourth-quarter results and suspended <a href="https://www.benzinga.com/trading-ideas/technicals/24/10/41493540/stock-of-the-day-starbucks-finds-support-at-94-will-a-bidding-war-force-stock-into-an-up">its guidance for 2025.&nbsp;</a>
The Details: In a surprise move, Starbucks reported <a href="https://www.benzinga.com/news/earnings/24/10/41468529/starbucks-stock-stumbles-after-company-reports-weak-preliminary-results-suspends-guidance">preliminary results</a> for the fourth quarter showing that it expects consolidated net revenues to decline 3% and global comparable sales to fall 7%. Starbucks also said it anticipates earnings of 80 cents per share, down 25% year-over-year.&nbsp;
KeyBanc Captial Markets analyst Eric Gonzalez said that though investors had braced for disappointing fourth-quarter results from Starbucks, they may not have been prepared for the "magnitude of the top- and bottom-line miss." 
Gonzalez did express confidence in the leadership of new CEO Brian Niccol and pointed to his successful tenure as CEO at Chipotle Mexican Grill.&nbsp;
BofA Securities analyst Sara Senatore also highlighted Niccol's successful turnaround of Chipotle and see him as "well-suited" for a Starbucks turnaround. BofA Securities reiterated its Buy rating and $117 price target and said the Starbucks brand "remains fundamentally strong."
Read Next: <a href="https://www.benzinga.com/news/24/10/41418987/nuclear-energy-stocks-are-hot-heres-a-list-of-tickers-to-watch">Nuclear Energy Stocks Are Hot: Here&#8217;s A List Of Tickers To Watch</a>
Stifel analyst Chris O'Cull echoed similar sentiments regarding the abilities of Niccol as CEO and said he is "zeroing in on the correct issues" in his "Back To Starbucks" strategy. Stifel maintained its Buy rating but lowered its price target from $110 to $105.&nbsp;
Looking ahead, Goldman Sachs analysts said they will be watching for more details on the "Back to Starbucks" plan in the company's earnings call on Oct. 30 after the closing bell. Goldman Sachs specifically will listen for more details on the company's pricing strategy, key marketing message and required store-level investments needed to address staffing issues and removing bottlenecks. 
Goldman Sachs analyst Christine Cho maintained Starbucks with a Buy rating and lowered the price target from $110 to $105.
Other analysts updated coverage on Starbucks as well:&nbsp;
<ul>
<li>TD Cowen analyst Andrew Charles reiterated a Buy rating and $110 price target.</li>
<li>UBS analyst Dennis Geiger maintained a Neutral rating but raised the price target from $85 to $95.</li>
</ul>
Starbucks will report its fourth-quarter results after the market close on Oct. 30, followed by a conference call at 5 p.m. ET.
SBUX Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Starbucks shares are down 0.64% at $96.21 at the time of publication Wednesday.
Read Also:&nbsp;
<ul>
<li>&nbsp;<a href="https://www.benzinga.com/news/24/10/41415824/lucid-ceo-peter-rawlinson-talks-saudi-investment-elon-musks-political-views-and-taking-business-from">Lucid CEO Peter Rawlinson Talks Saudi Investment, Elon Musk&#8217;s Political Views And Taking Business From Tesla</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings

Guidance

SBUX

Starbucks Analysts Bullish On CEO Brian Niccol After Tough Preannouncement: 'Zeroing In' On Right Issues

How is SPY stock faring? The SPDR S&P 500 ETF Trust&nbsp;is up 1.16% in the past five days and has risen 34.72% over the past year. According to Ti...

SPY ETF Update, 10/14/2024

The Bull's Biggest Hits And Misses

How is VOO stock faring? The Vanguard S&P 500 ETF is up 1.49% in the past five days and has risen 34.86% over the past year.  According to TipRanks...

VOO ETF Update, 10/15/2024

Warner Bros. Discovery ($WBD) is expanding its Max streaming service to Southeast Asia. Starting November 19, consumers in seven Asian regions—Indo...

Warner Bros. Discovery's (WBD) Max Streaming Service to Debut in Southeast Asia

Warner Bros. Discovery expands Max to 7 Asian countries

The S&P 500 election-year implied return from now until year-end reaches 6,200 – analyst

Entertainment giant Disney ($DIS) has long had troubles surrounding the costs of its theme parks. In fact, for many customers, a day at Disney is i...

Goldman Sachs: Disney (NYSE:DIS) New Pass Leaves Concern All Around

Disney's (NYSE:DIS) New Pass Leaves Concern All Around

"Box Office Battle" is The Fly's weekly roundup of what movies topped the weekend's box office. Paramount's (PARA) "Smile 2" won this weekend at th...

Box Office Battle: 'Smile 2' wins weekend with $23 opening

Circana analyst Mat Piscatella said that projected U.S. total spending on video game hardware, content and accessories fell 6% during September 202...

U.S. video game spending fell 6% year-over-year in September, says Circana

ALLE

AMZN

ANET

AVGO

AXON

BIIB

BLDR

CMCSA

DELL

DLTR

DXCM

ENPH

EPAM

FICO

JBHT

MRNA

MSFT

NFLX

NTDOF

NTDOY

NVDA

NWSA

PARA

PARAA

PAYC

PLTR

SMCI

SNEJF

SONY

TTWO

UBER

UBSFY

Screenshot 2024-06-10 at 5.33.14 PM

Emerging Markets

Movers & Shakers

IZEA

How IZEA Worldwide (NASDAQ: IZEA) Is Leading The World Into The Creator Economy Era

Entertainment

Press Releases

WARNER BROS. DISCOVERY ANNOUNCES CONFERENCE PARTICIPATION FOR THE MONTH OF SEPTEMBER

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Warner Bros. Discovery, Inc. - WBD

The New York Latino Film Festival, Presented By Warner Bros. Discovery, Returns September 15-22, 2024 Opening With 'Clemente' Executive Produced By LeBron James and Oscar-Nominated Director Richard Linklater

WARNER BROS. DISCOVERY TO REPORT THIRD-QUARTER 2024 RESULTS ON THURSDAY, NOVEMBER 7

Contracts

WARNER BROS. DISCOVERY AND CHARTER COMMUNICATIONS ANNOUNCE EARLY RENEWAL AGREEMENT THAT FURTHER REIMAGINES THE FUTURE OF VIDEO

Warner Bros. Discovery Deploys AI-Powered Captioning Solution Built Using Google Cloud AI

CHTR

AMC Entertainment Holdings, Inc. Class A Common Stock

AMC Enter Hldgs

Atlanta Braves Holdings, Inc. - Series A Common Stock

Atlanta Braves Holdings

Atlanta Braves Holdings, Inc. - Series C Common Stock

Cinemark Holdings Inc Cinemark Holdings, Inc. Common Stock

Cinemark Hldgs

Walt Disney

Endeavor Group Holdings, Inc. Class A Common Stock

Endeavor Gr Hldgs

Liberty Media Corporation - Series A Liberty Formula One Common Stock

Liberty Formula One Gr

Ordinary Shares (New Liberty Formula One) Series A

Liberty Media Corporation - Series C Liberty Formula One Common Stock

Ordinary Shares (New Liberty Formula One) Series C

iQIYI

Lions Gate Entertainment Corporation Class A Voting Shares

Lions Gate Entertainment Corporation Class B Non-Voting Shares

Lionsgate Studios

Liberty Media Corporation - Series A Liberty Live Common Stock

Liberty Live

Ordinary Shares (New Liberty Live) Series A

Liberty Media Corporation - Series C Liberty Live Common Stock

Ordinary Shares (New Liberty Live) Series C

Live Nation Entertainment, Inc. Common Stock

Live Nation Entertainment

Manchester United Ltd. Class A Ordinary Shares

Manchester United

Madison Square Garden Entertainment Corp. Class A Common Stock

Madison Square Garden

Madison Square Garden Sports Corp. Class A Common Stock (New)

Netflix

Roku

Reservoir Media

Sphere Entertainment Co. Class A Common Stock

Sphere Entertainment

TKO Group Holdings, Inc. Class A Common Stock

TKO Group Holdings

Tencent Music Entertainment Group American Depositary Shares, each representing two Class A Ordinary Shares

Comments

Warner Bros. Discovery

Warner Bros. Discovery (WBD) Opzioni

Warner Bros. Discovery (NASDAQ:WBD) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO